Abstract

Iron overload is a significant concern in beta-thalassemia major and intermedia patients. These conditions lead to reduced production of hemoglobin, necessitating frequent blood transfusions. As a result, excess iron accumulates in the body, primarily in vital organs like the heart and liver. This can cause serious complications, including heart failure and liver damage. To manage iron overload, patients often require chelation therapy, which involves the use of medications to remove excess iron from the body. Regular monitoring and treatment are essential to mitigate the long-term consequences of iron overload in these individuals. This is a study to create awareness about the consequences of iron overload in the patients of West Bengal.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call